- Processing Solutions
- White Papers
- Buyer's Guide
TOKYO — Takeda Pharmaceutical Co., Asia’s biggest drugmaker, fell 4.3% in Tokyo trading after forecasting a 40% drop in operating profit, Bloomberg reported.
The fall was the most in 14 months.
The company said the drop in operating profit was due to acquisition costs and higher research expenses.